Masafumi Oyama

Years Active: 2023-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Makito Miyake, Nobutaka Nishimura, Tomonori Nakahama, Koshiro Nishimoto, Masafumi Oyama, Yuto Matsushita, Hideaki Miyake, Hideo Fukuhara, Keiji Inoue, Keita Kobayashi, Hiroaki Matsumoto, Hideyasu Matsuyama, Tomomi Fujii, Yoshihiko Hirao, Kiyohide Fujimoto
Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non-muscle-invasive bladder cancer: A comparative study from experienced institutes. BJUI compass 4 (3) (2023)
Takafumi Saito, Kent Kanao, Kazuhiro Matsumoto, Keishiro Fukumoto, Daisuke Igarashi, Takayuki Takahashi, Go Kaneko, Suguru Shirotake, Koshiro Nishimoto, Ryuichi Mizuno, Masaru Ishida, Satoshi Hara, Mototsugu Oya, Masafumi Oyama
New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinoma. BJUI compass 5 (2) (2023)
Takafumi Saito, Kent Kanao, Kazuhiro Matsumoto, Keishiro Fukumoto, Daisuke Igarashi, Takayuki Takahashi, Go Kaneko, Suguru Shirotake, Koshiro Nishimoto, Ryuichi Mizuno, Masaru Ishida, Satoshi Hara, Mototsugu Oya, Masafumi Oyama
New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinoma. BJUI compass 5 (2) (2023)

Masafumi Oyama.css-eqlu8i{font-size:small;padding-left:4px;}